Cisplatin Tumor Biodistribution and Efficacy after Intratumoral Injection of a Biodegradable Extended Release Implant
Figure 6
Cisplatin tumor tissue distribution after intratumoral injection of cisplatin/polymer formulation (1% w/w, 50 μL). Each curve represents a different time point when the mice were sacrificed and their tumors processed. Values are expressed as mean ().
